DA
INSM icon

Duality Advisers’s Insmed INSM Stock Holding History

Duality Advisers’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-72,364
Closed -$1.56M – 675
2022
Q3 		$1.56M Buy
+72,364
New +$1.73M 0.17% 233
2022
Q2 		– Sell
-8,901
Closed -$209K – 719
2022
Q1 		$209K Buy
+8,901
New +$207K 0.02% 596

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Duality Advisers's INSM Position: Q4 2022 in Review

Duality Advisers sold out of Insmed (INSM) in Q4 2022, closing a stake of 72,364 shares — an estimated $1.56M sold.

Duality Advisers first reported a position in INSM in Q1 2022 and held it in 2 quarters. The position peaked at $1.56M in Q3 2022. 225 funds tracked by Wall St. Rank hold INSM as of Q4 2022.

  • Duality Advisers reported no remaining Insmed position as of Q4 2022 after selling out during the quarter.
  • Duality Advisers sold 72,364 Insmed shares in Q4 2022, an estimated $1.56M.
  • Duality Advisers first reported a position in Insmed in Q1 2022 and held it in 2 quarters.
  • Duality Advisers's Insmed position peaked at $1.56M in Q3 2022.
  • 225 funds tracked by Wall St. Rank held Insmed as of Q4 2022.

Based on Duality Advisers's 13F filing for Q4 2022, filed 7 Feb 2023.